Tweedy, Browne Co All Funds (US) recent buys & sells (2016 Q2)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US) Portfolio Changes
Purchase & sale details
- Portfolio value:
- $3.56B~ (-$69M~)
- Previous value:
- $3.63B~
- # of changes:
- 45
- New positions:
- 2
- Reported for:
- 30 Jun 2016 (Q2)
- Latest filing date:
- 10 Aug 2016
Tweedy, Browne Co All Funds (US) has disclosed a total of 45 changes to the portfolio in the (2016 Q2) SEC report(s): increased the number of shares of 7, bought 2 totally new, decreased the number of shares of 34 and completely sold out 2 position(s).
What stocks did Tweedy, Browne Co All Funds (US) buy in 2016 Q2?
During 2016 Q2 Tweedy, Browne Co All Funds (US) has bought 9 securities out of which top 5 purchases (by % change to portfolio) were (WFC) Wells Fargo & Company (added shares +8.12%), (VZ) Verizon Communications Inc (added shares +2.07%), (AGCO) AGCO Corp (added shares +0.88%), (AVT) Avnet Inc (added shares +7.58%) and (SHPG) Shire plc (new buy).
What did Tweedy, Browne Co All Funds (US) invest in during 2016 Q2?
45 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Shire plc
|
new
|
$184.06
|
|
0.22%
|
2016 Q2
|
~0.25 years
|
||||
|
|
Exxon Mobil Corp
|
new
|
$93.91
|
|
0.01%
|
2016 Q2
|
~0.25 years
|
||||
|
|
Wells Fargo & Company
|
+8.12%
|
$47.33
|
+87.28%($88.64)
|
6.65%
|
2013 Q2*
|
> 3 years
|
||||
|
|
Avnet Inc
|
+7.58%
|
$40.51
|
+132.41%($94.15)
|
0.82%
|
2016 Q1
|
~0.50 years
|
||||
|
|
SHELL PLC-SPON ADR-A
|
+5.25%
|
$55.23
|
|
0.09%
|
2013 Q2*
|
> 3 years
|
||||
|
|
HSBC Holdings PLC ADR
|
+3.91%
|
$31.31
|
+225.54%($101.92)
|
0.16%
|
2013 Q2*
|
> 3 years
|
||||
|
|
Verizon Communications Inc
|
+2.07%
|
$55.84
|
-9.84%($50.34)
|
2.59%
|
2014 Q3
|
~2.00 years
|
||||
|
|
AGCO Corp
|
+0.88%
|
$47.13
|
+155.51%($120.42)
|
1.03%
|
2014 Q4
|
~1.75 years
|
||||
|
|
GlaxoSmithKline PLC ADR
|
+0.36%
|
$54.18
|
-7.23%($50.26)
|
0.14%
|
2013 Q2*
|
> 3 years
|
||||
|
|
Alphabet Inc, CL-C
|
-0.03%
|
$34.60
|
+887.37%($341.68)
|
2.72%
|
2014 Q1
|
~2.50 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".